// App-Quantinova.ai

: Evaluation of Anti-PF4 Positivity and Platelet Activation after COVID-19 Vaccination with Ad26.COV2.S in Brazil

Researchers

Presenter

  • Joanna Bokel

Principal Investigators

  • Daniela P. Mendes-de-Almeida

  • Remy Martins-Gonçalves

  • Eduarda Grinsztejn

  • Brenda Hoagland

  • Sandra Wagner

  • Kim Mattos Geraldo

  • Sandro Nazer Coutinho

  • Ingebourg Georg

  • Maria Helena Oliveira de Mello

  • Flávia dos Santos Souza

  • Alexandre G. Vizzoni

  • Valdilea Veloso

  • Patrícia T. Bozza

  • Beatriz Grinsztejn

Medical Centers

  • Instituto Oswaldo Cruz IOC/FIOCRUZ, Rio de Janeiro, Brazil

  • Instituto Nacional de Infectologia Evandro Chagas INI/FIOCRUZ, Rio de Janeiro, Brazil

  • Hematology-Oncology Department, University Hospitals, Case Western Reserve University, Cleveland, OH

Locations

  • Brazil

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Infectious Diseases (ID)

Disease

  • Thrombocytopenia

  • Venous thrombosis

  • Coronavirus disease

Biomarkers

  • D-dimer

  • Immunoglobulin G

  • Platelet count

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved